Resources from the same session
Checkpoint inhibition beyond anti-PD(L)1 and anti-CTLA4: What progress?
Presenter: Han Chong Toh
Session: Cancer immunotherapy in 2022
Resources:
Slides
Webcast
Cellular therapy: Finally prime time in solid tumours?
Presenter: Inge-Marie Svane
Session: Cancer immunotherapy in 2022
Resources:
Slides
Webcast
Q&A and discussion
Presenter: Inge-Marie Svane
Session: Cancer immunotherapy in 2022
Resources:
Slides
Webcast